Proposed Collection; 60 Day Comment Request; Women's Health Initiative (NHLBI), 19207-19208 [2016-07487]

Download as PDF Federal Register / Vol. 81, No. 64 / Monday, April 4, 2016 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Precision Medicine Initiative Cohort Program Biobank. Date: April 18, 2016. Time: 9:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Lorien Hotel & Spa, 1600 King Street, Alexandria, VA 22314. Contact Person: Delia Olufokunbi Sam, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3158, MSC 7770, Bethesda, MD 20892, 301–435– 0684, olufokunbisamd@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: March 29, 2016. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–07489 Filed 4–1–16; 8:45 am] as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Extramural Loan Repayment Program for Clinical Research (LRP–CR) NOT–OD–15–121 and Extramural Loan Repayment Program for Clinical Research (LRP–PR) NOT–OD–15–122. Date: April 24–30, 2016. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Annie Walker-Abbey, Scientific Review Officer, Scientific Review Program, NIAID/NIH/DHHS, 5601 Fishers Lane, Room 3E70A, Rockville, MD 20852, 240–627–3390, aabbey@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Clinical Trial Planning Grant (R34) and Implementation Cooperative Agreement (U01). Date: May 3, 2016. Time: 12:30 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Room NIAID 4H100 Resource Library, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Maryam Feili-Hariri, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/ NIAID, 5601 Fishers Lane, Rockville, MD 20852, 240–669–5026, haririmf@ niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS). Dated: March 28, 2016. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2016–07498 Filed 4–1–16; 8:45 am] BILLING CODE 4140–01–P National Institutes of Health mstockstill on DSK4VPTVN1PROD with NOTICES National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings DEPARTMENT OF HEALTH AND HUMAN SERVICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., National Institutes of Health VerDate Sep<11>2014 19:03 Apr 01, 2016 Jkt 238001 Proposed Collection; 60 Day Comment Request; Women’s Health Initiative (NHLBI) Summary: In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, PO 00000 Frm 00096 Fmt 4703 Sfmt 4703 19207 for opportunity for public comment on proposed data collection projects, the National Heart, Lung, and Blood Institute (NHLBI), the National Institutes of Health (NIH), will publish periodic summaries of proposed projects to the Office of Management and Budget (OMB) for review and approval. Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. To Submit Comments and for Further Information: To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Shari Ludlam, 6701 Rockledge Drive, MSC 7936, Bethesda, MD 20892, or call non-toll-free number (301) 435–6667, or Email your request to: ludlams@mail.nih.gov. Formal requests for additional plans and instruments must be requested in writing. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: The Women’s Health Initiative, 0925–0414, Revision, Exp. 7/31/2016, National Heart, Lung, and Blood Institute (NHLBI), the National Institutes of Health (NIH). Need and Use of Information Collection: This proposal is to extend the Women’s Health Initiative (WHI), which comprises a group of research studies that will address critical issues about the most common causes of frailty, disability, and death among postmenopausal women aged 50 to 79 years. This Initiative is comprised of two main investigational approaches: (1) A large clinical trial (CT) to evaluate the clinical efficacy of promising, but unproven preventive approaches for specific diseases common among older women; and (2) a companion observational E:\FR\FM\04APN1.SGM 04APN1 19208 Federal Register / Vol. 81, No. 64 / Monday, April 4, 2016 / Notices study (OS) comprised of women ineligible or unwilling to participate in the CT, to evaluate risk factors for chronic diseases by following this large cohort of women and relating subsequent disease development to baseline assessments of historical, physical, and physiologic characteristics. The WHI provides new information on health and risk of disease among older post-menopausal women to inform development of approaches to disease prevention. The specific objectives of the OS are to provide reliable estimates of the extent to which known risk factors predict heart disease, cancers and fractures; identify new risk factors for these and other diseases in women; compare risk factors, presence of disease at the start of the study, and new occurrences of disease during the WHI in all study components; and create a future resource to identify biological indicators of disease, especially substances and factors found in the blood. Continued follow-up of medical outcome occurrences will enhance achievement of the WHI original goals and increase the range of scientific issues that can be examined. Specific biomarkers will be assessed based on current and future hypotheses related to clinical endpoints. The WHI study/protocol allows for analysis and presentation of results in aggregate form only, thus all data including biological samples are void of personal identifiers. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 10,796. A.12–1—ESTIMATED ANNUALIZED BURDEN HOURS Form name Form Form Form Form Form Number of respondents Type of respondent Number of responses per respondent Average burden per response (In hours) Total annual burden hours 33 Medical History Update .................. 151 Activities of Daily Life ................... 20 Personal Information Update ......... 120 Initial Notification of Death ........... 120 Initial Notification of Death ........... OS Participants .................... OS Participants .................... OS Participants .................... Next of Kin ............................ Physician/Office Staff ........... 40203 40203 40203 900 15 1 1 1 1 1 7/60 6/60 3/60 5/60 5/60 4690 4020 2010 75 1 Total ....................................................... ............................................... 41,118 41,118 ........................ 10,796 Dated: March 23, 2016. Valery Gheen, NHLBI Project Clearance Liaison, National Institutes of Health. [FR Doc. 2016–07487 Filed 4–1–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health mstockstill on DSK4VPTVN1PROD with NOTICES Office of the Director, National Institutes of Health; Notice of Meeting Notice is hereby given of a meeting of the Big Data to Knowledge MultiCouncil Working Group. The teleconference meeting will be open to the public as indicated below. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Working Group: Big Data to Knowledge Multi-Council Working Group. Date: April 25, 2016. Open: 11:00 a.m. to 12:30 p.m. Agenda: April 2016 MCWG Open Session, Discussion will review current Big Data to Knowledge (BD2K) activities and newly proposed BD2K initiatives. Place: Teleconference, Join WebEx meeting, Telephone Number: 1–877– VerDate Sep<11>2014 19:03 Apr 01, 2016 Jkt 238001 668–4493, Meeting Number: 622 421 867. Note: This portion of the meeting is open to the public but is being held by teleconference only. No physical meeting location is provided for any interested individuals to listen to committee discussions. Any individual interested in listening to the meeting discussions must call: 1–877–668–4493 and use Meeting number: 622 421 867 for access to the meeting. Participants can also join in on the viewing the presentation by clicking the following link Join WebEx meeting. Any interested person may file written comments with the working group or submit questions by sending an email to the Contact Person listed on this notice. The email should include the name, addresses, telephone number and when applicable, the business or professional affiliation of the interested person. Closed: 12:30 p.m.–3:30 p.m. Agenda: April 2016 MCWG Closed Session, Discussion will focus on review of proposed Funding Plans for BD2K Funding Opportunity Announcements. Place: Teleconference. Contact Person: Tonya Scott, Scientific Program Analyst, Office of the Associate Director of Data Science (ADDS), National Institutes of Health, 1 Center Drive, Room 325, Bethesda, MD 20892, email: tonya.scott@nih.gov, Telephone: 301–402–9817. PO 00000 Frm 00097 Fmt 4703 Sfmt 4703 Additional information on data science is available at: https:// datascience.nih.gov/index and additional information on the Working Group is available at: https:// datascience.nih.gov/bd2k/about/org/ MCWG. Dated: March 29, 2016. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2016–07542 Filed 4–1–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center For Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which E:\FR\FM\04APN1.SGM 04APN1

Agencies

[Federal Register Volume 81, Number 64 (Monday, April 4, 2016)]
[Notices]
[Pages 19207-19208]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07487]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Proposed Collection; 60 Day Comment Request; Women's Health 
Initiative (NHLBI)

    Summary: In compliance with the requirement of Section 
3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity 
for public comment on proposed data collection projects, the National 
Heart, Lung, and Blood Institute (NHLBI), the National Institutes of 
Health (NIH), will publish periodic summaries of proposed projects to 
the Office of Management and Budget (OMB) for review and approval.
    Written comments and/or suggestions from the public and affected 
agencies are invited on one or more of the following points: (1) 
Whether the proposed collection of information is necessary for the 
proper performance of the function of the agency, including whether the 
information will have practical utility; (2) The accuracy of the 
agency's estimate of the burden of the proposed collection of 
information, including the validity of the methodology and assumptions 
used; (3) Ways to enhance the quality, utility, and clarity of the 
information to be collected; and (4) Ways to minimize the burden of the 
collection of information on those who are to respond, including the 
use of appropriate automated, electronic, mechanical, or other 
technological collection techniques or other forms of information 
technology.
    To Submit Comments and for Further Information: To obtain a copy of 
the data collection plans and instruments, submit comments in writing, 
or request more information on the proposed project, contact: Shari 
Ludlam, 6701 Rockledge Drive, MSC 7936, Bethesda, MD 20892, or call 
non-toll-free number (301) 435-6667, or Email your request to: 
ludlams@mail.nih.gov. Formal requests for additional plans and 
instruments must be requested in writing.
    Comments Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 60 days 
of the date of this publication.
    Proposed Collection: The Women's Health Initiative, 0925-0414, 
Revision, Exp. 7/31/2016, National Heart, Lung, and Blood Institute 
(NHLBI), the National Institutes of Health (NIH).
    Need and Use of Information Collection: This proposal is to extend 
the Women's Health Initiative (WHI), which comprises a group of 
research studies that will address critical issues about the most 
common causes of frailty, disability, and death among post-menopausal 
women aged 50 to 79 years. This Initiative is comprised of two main 
investigational approaches: (1) A large clinical trial (CT) to evaluate 
the clinical efficacy of promising, but unproven preventive approaches 
for specific diseases common among older women; and (2) a companion 
observational

[[Page 19208]]

study (OS) comprised of women ineligible or unwilling to participate in 
the CT, to evaluate risk factors for chronic diseases by following this 
large cohort of women and relating subsequent disease development to 
baseline assessments of historical, physical, and physiologic 
characteristics. The WHI provides new information on health and risk of 
disease among older post-menopausal women to inform development of 
approaches to disease prevention. The specific objectives of the OS are 
to provide reliable estimates of the extent to which known risk factors 
predict heart disease, cancers and fractures; identify new risk factors 
for these and other diseases in women; compare risk factors, presence 
of disease at the start of the study, and new occurrences of disease 
during the WHI in all study components; and create a future resource to 
identify biological indicators of disease, especially substances and 
factors found in the blood. Continued follow-up of medical outcome 
occurrences will enhance achievement of the WHI original goals and 
increase the range of scientific issues that can be examined. Specific 
biomarkers will be assessed based on current and future hypotheses 
related to clinical endpoints. The WHI study/protocol allows for 
analysis and presentation of results in aggregate form only, thus all 
data including biological samples are void of personal identifiers.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 10,796.

                                    A.12-1--Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                     Type of         Number of       Number of      burden per     Total annual
           Form name               respondent       respondents    responses per   response  (In   burden hours
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Form 33 Medical History Update  OS Participants.           40203               1            7/60            4690
Form 151 Activities of Daily    OS Participants.           40203               1            6/60            4020
 Life.
Form 20 Personal Information    OS Participants.           40203               1            3/60            2010
 Update.
Form 120 Initial Notification   Next of Kin.....             900               1            5/60              75
 of Death.
Form 120 Initial Notification   Physician/Office              15               1            5/60               1
 of Death.                       Staff.
                                                 ---------------------------------------------------------------
    Total.....................  ................          41,118          41,118  ..............          10,796
----------------------------------------------------------------------------------------------------------------


    Dated: March 23, 2016.
Valery Gheen,
NHLBI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2016-07487 Filed 4-1-16; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.